2 results
Approved WMOCompleted
This study is designed to assess the safety and efficacy of aztreonam for inhalation solution/aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in subjects with non-CF bronchiectasis and gram-negative endobronchial infection.
Approved WMORecruiting
1) To identify new predictors of ST, especially 'late' and 'very late ST', 'drug eluting ST' and 'bio-absorbable scaffold thrombosis'.2) To observe clinical outcome after an episode of ST